Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170038/S023

CentriMag Circulatory Support System

Abbott · Decision date Sep 29, 2025

FDA DECISIONP170038/S023

What did the FDA approve?

FDA records P170038/S023 as a supplement to PMA P170038, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Sep 29, 2025.

FDA approval order statement

Approval for a design change to the AC/DC power supply of the CentriMag Console.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Sep 29, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P170038/S023
Regulatory pathway
PMA supplement
Applicant
Abbott
Product code
DSQ
Decision code
APPR
Decision date
Sep 29, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Applicant
Abbott
Product code
DSQ
FDA device class
3

For the original device and its historical approval scope, see PMA P170038. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P170038 · Original PMA

    CentriMag Circulatory Support System

  2. P170038/S023 received

    Application receipt date recorded by FDA.

  3. P170038/S026 · Related supplement

    CentriMag Circulatory Support System

  4. P170038/S023 · FDA decision

    Real-Time Process

  5. P170038/S025 · Related supplement

    CentriMag Circulatory Support System

  6. P170038/S027 · Related supplement

    CentriMag Circulatory Support System

  7. P170038/S028 · Related supplement

    CentriMag Circulatory Support System

  8. P170038/S029 · Related supplement

    CentriMag Circulatory Support System

  9. P170038/S030 · Related supplement

    CentriMag Circulatory Support System

  10. P170038/S031 · Related supplement

    CentriMag Circulatory Support System

  11. P170038/S032 · Related supplement

    CentriMag Circulatory Support System

  12. P170038/S033 · Related supplement

    CentriMag Circulatory Support System

  13. P170038/S034 · Related supplement

    CentriMag Circulatory Support System

Timeline entries are records held by MedtechLedger for P170038. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170038

Product / regulatory recordCompanyPathwayDecision dateSource
AbbottPMA approvalDec 6, 2019FDA
AbbottPMA supplementAug 21, 2025FDA
AbbottPMA supplementDec 1, 2025FDA
AbbottPMA supplementFeb 3, 2026FDA
AbbottPMA supplementFeb 18, 2026FDA
AbbottPMA supplementApr 17, 2026FDA
AbbottPMA supplementMay 4, 2026FDA
AbbottPMA supplementMay 5, 2026FDA
AbbottPMA supplementSep 2, 2026FDA
AbbottPMA supplementOct 2, 2026FDA
AbbottPMA supplementOct 30, 2026FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA
Berlin Heart, Inc.PMA supplementOct 28, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
ABBOTT MEDICALPMA supplementOct 19, 2026FDA
Berlin Heart, Inc.PMA supplementOct 14, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6035 Stoneridge Dr., Pleasanton, CA, 94588

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records